A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions

Healthy

Interventions

DRUG

PF-07976016

Oral solution, oral suspension or solid oral formulation(s)

DRUG

Placebo

Oral solution, oral suspension or solid oral formulation(s)

DRUG

Midazolam

Midazolam oral solution

Trial Locations (1)

Pfizer Clinical Research Unit - New Haven, New Haven